| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $117.0M | +37.6% |
| SG&A Expense | $72.9M | +145.5% |
| Operating Income | -$189.9M | -65.5% |
| Pre-tax Income | -$185.2M | -61.7% |
| Income Tax | $0 | — |
| Net Income | -$185.2M | -61.7% |
| EPS (Basic) | -$1.53 | -36.6% |
| EPS (Diluted) | -$1.53 | -36.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $476.3M | +82.2% |
| Current Assets | $662.8M | +71.1% |
| Total Assets | $666.8M | +71.3% |
| Current Liabilities | $35.6M | +26.1% |
| Long-term Debt | $96.6M | — |
| Total Liabilities | $132.2M | +358.4% |
| Stockholders' Equity | $534.7M | +48.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$163.8M | -66.2% |
| Capital Expenditures | $736K | +103.9% |
| Investing Cash Flow | -$50.3M | -336.1% |
| Financing Cash Flow | $428.9M | +57.5% |
| Free Cash Flow | -$164.5M | -66.3% |